Shownotes
Dr Sam Moxon, narrates his blog written for Dementia Researcher.
In this blog Sam reflects on his move from academia into running a university spinout and what that shift has taught him about the role of business in dementia research. He explains why funding decisions, investor confidence, and commercial risk shape which ideas progress and which fall away. Using recent industry examples, he explores how failed trials affect not only companies but the wider research ecosystem, and why understanding these pressures matters for everyone working towards better treatments.
Find the original text, and narration here on our website.
https://www.dementiaresearcher.nihr.ac.uk/blog-why-the-business-side-of-dementia-research-matters/
--
Dr Sam Moxon is a biomaterials Research Fellow at University of Birmingham. His expertise falls on the interface between biology and engineering. His PhD focussed on regenerative medicine and he now works on trying to develop 3D bioprinting techniques with human stem cells, so that we better understand and treat degenerative diseases. Outside of the lab he hikes through the Lake District and is an expert on all things Disney.
--
Enjoy listening and reading our blogs? We're always on the look out for new contributors, drop us a line and share your own research and careers advice dementiaresearcher@ucl.ac.uk
This podcast is brought to you in association with the NIHR, Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support.
--
Follow us on Social Media:
Join our community:
https://onelink.to/dementiaresearcher
